Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
New England Journal of Medicine
DOI
Abstract
Rheumatic heart disease affects more than 40.5 million people worldwide and results in 306,000 deaths annually. Echocardiographic screening detects rheumatic heart disease at an early, latent stage. Whether secondary antibiotic prophylaxis is effective in preventing progression of latent rheumatic heart disease is unknown.
Description
Citation
Beaton, A., Okello, E., Rwebembera, J., Grobler, A., Engelman, D., Alepere, J., ... & Steer, A. C. (2022). Secondary antibiotic prophylaxis for latent rheumatic heart disease. New England Journal of Medicine, 386(3), 230-240.DOI: 10.1056/NEJMoa2102074